Institutional Ownership
Cns Pharmaceuticals Inc
CUSIP 18978H508COMCNSPQ1 2026
Institutional Holders
11
13F filers
Shares Held
145.6K
Aggregate institutional
Institutional Value
$348.7K
Q1 2026
Net New Holders
+2
4 new · 2 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions4
Increased2
Decreased0
Sold out2
Institutional Holders
11 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Stonepine Capital Management, LLC | 61.0K | $145.8K | +12.2K | Added |
| 2 | Ikarian Capital, LLC | 45.8K | $110.0K | 0 | Held |
| 3 | Geode Capital Management, LLC | 23.2K | $55.7K | +23.2K | New |
| 4 | Boothbay Fund Management, LLC | 13.5K | $32.3K | 0 | Held |
| 5 | Tower Research Capital LLC (Trc) | 1.3K | $3.1K | +1.3K | New |
| 6 | Ubs Group AG | 729 | $1.7K | +118 | Added |
| 7 | Barrett & Company, Inc. | 8 | $19 | 0 | Held |
| 8 | Mai Capital Management | 3 | $8 | 0 | Held |
| 9 | Danske Bank A/S | 1 | $2 | 0 | Held |
| 10 | Citigroup Inc | 1 | $2 | +1 | New |
1 more institutional holders on Premium
See every fund holding Cns Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders